Ammon News - Sunday, the price of gold in local market stabilized, according to the General Syndicate of Owners of Trade and ...

Johnson & Johnson's latest effort to end tens of thousands of talc lawsuits has sparked a new legal battle between plaintiffs ...

The U.S. Food and Drug Administration has allowed the expanded use of Johnson & Johnson's drug, Tremfya, to treat adults with ...

Johnson & Johnson already has a major presence in the crowded inflammatory bowel disease (IBD) space with its popular Stelara ...

Share on Facebook Share on Twitter If you missed it, late in the show yesterday the CMA nominations were announced. Morgan ...

Mecktoberfest at The Olde Mecklenburg Brewery will take place four weekends in September and October, Friday through Sunday.

Share on Facebook Share on Twitter Today, we salute Navy Veteran Jim Serger.  Jim has been on a mission to share the stories ...

The Biden administration’s drug-price negotiation law threatens new product development and will lead to fewer new medicines ...

THE US Food and Drug Administration has allowed the expanded use of Johnson & Johnson's drug, Tremfya, to treat adults with a type of chronic inflammatory bowel disease, the company said on Wednesday.

A US government agency has hit back at a plan by Johnson & Johnson to change the way it pays discounts on drugs to hospitals participating in the 340B programme for healthcare systems serving ...

Sanofi is trumpeting new data for its anti-CD38 drug Sarclisa as it tries to capture market share from Johnson & Johnson’s blockbuster Darzalex in the multiple myeloma market. A couple of months ...